3.6(top 10%)
impact factor
90(top 100%)
papers
2.5K(top 20%)
citations
29(top 20%)
h-index
3.9(top 10%)
extended IF
98
all documents
2.7K
doc citations
47(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Chemotherapy Resistance in Advanced Ovarian Cancer PatientsBiomarkers in Cancer2019206
2Molecular Profiling for Breast Cancer: A Comprehensive ReviewBiomarkers in Cancer2013155
3Deep Sequencing of Serum Small RNAs Identifies Patterns of 5′ tRNA Half and YRNA Fragment Expression Associated with Breast CancerBiomarkers in Cancer2014146
4Biomarkers for Hepatocellular CarcinomaBiomarkers in Cancer2017116
5BRAF Mutation in Colorectal Cancer: An UpdateBiomarkers in Cancer2015107
6Predicting Clinical Outcomes Using Molecular BiomarkersBiomarkers in Cancer201692
7Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane ProteinsBiomarkers in Cancer201685
8Tissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaBiomarkers in Cancer201681
9The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsBiomarkers in Cancer201670
10The Prognostic Value of the Apoptosis Pathway in Colorectal Cancer: A Review of the Literature on Biomarkers Identified by ImmunohistochemistryBiomarkers in Cancer201365
11Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine SamplesBiomarkers in Cancer201060
12Biomarkers of Angiogenesis in Colorectal CancerBiomarkers in Cancer201559
13Ameloblastoma: A Review of Recent Molecular Pathogenetic DiscoveriesBiomarkers in Cancer201558
14Role of Biomarkers in the Development of PARP InhibitorsBiomarkers in Cancer201658
15Human Cancer Immunotherapy with PD-1/PD-L1 BlockadeBiomarkers in Cancer201551
16Novel Molecular Markers for Breast CancerBiomarkers in Cancer201649
17Biomarkers and Targeted Therapy in Pancreatic CancerBiomarkers in Cancer201645
18Urine Biomarkers for the Early Detection of Ovarian Cancer – Are We There Yet?Biomarkers in Cancer201944
19CD151—A Striking Marker for Cancer TherapyBiomarkers in Cancer201543
20Targeted Radionuclide Therapy: Practical Applications and Future ProspectsBiomarkers in Cancer201643
21Circulating HER2 Extracellular Domain: A Specific and Quantitative Biomarker of Prognostic Value in all Breast Cancer Patients?Biomarkers in Cancer201340
22The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer TherapyBiomarkers in Cancer201639
23Interleukin 1β—A Potential Salivary Biomarker for Cancer Progression?Biomarkers in Cancer201537
24BMI1: A Biomarker of Hematologic MalignanciesBiomarkers in Cancer201636
25Identification of Gene Expression Signature in Estrogen Receptor Positive Breast CarcinomaBiomarkers in Cancer201035
26Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell CarcinomaBiomarkers in Cancer201335
27Simultaneous Underexpression of let-7a-5p and let-7f-5p microRNAs in Plasma and Stool Samples from Early Stage Colorectal CarcinomaBiomarkers in Cancer201534
28miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell CarcinomaBiomarkers in Cancer201733
29Elevated Expression of the Testis-specific Gene WBP2NL in Breast CancerBiomarkers in Cancer201532
30Long Noncoding RNAs as a Key Player in Hepatocellular CarcinomaBiomarkers in Cancer201732
31Imaging Biomarkers in ImmunotherapyBiomarkers in Cancer201631
32Microparticles as Biomarkers of Blood Coagulation in CancerBiomarkers in Cancer201528
33Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other CancersBiomarkers in Cancer201627
34Urinary 1-Hydroxypyrene as a Biomarker to Carcinogenic Polycyclic Aromatic Hydrocarbon ExposureBiomarkers in Cancer201225
35Tritsomy 8 Acute Myeloid Leukemia Analysis Reveals New Insights of DNA Methylome with Identification ofHHEXas Potential Diagnostic MarkerBiomarkers in Cancer201525
36Circulating Neutrophil MicroRNAs as Biomarkers for the Detection of Lung CancerBiomarkers in Cancer201625
37Serum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related MarkersBiomarkers in Cancer201124
38Oncogenes: The Passport for Viral Oncolysis through PKR InhibitionBiomarkers in Cancer201623
39Comparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and PaclitaxelBiomarkers in Cancer201622
40An Antibody-based Blood Test Utilizing a Panel of Biomarkers as a New Method for Improved Breast Cancer DiagnosisBiomarkers in Cancer201321
41Preoperative Serum Carcinoembryonic Antigen as a Marker for Predicting the Outcome of Three CancersBiomarkers in Cancer201721
42Association of MTHFR (C677T) Gene Polymorphism with Breast Cancer in North IndiaBiomarkers in Cancer201620
43Organic Anion Transporting Polypeptide 5A1 (OATP5A1) in Small Cell Lung Cancer (SCLC) Cells: Possible Involvement in Chemoresistance to SatraplatinBiomarkers in Cancer201119
44The VA Point-of-Care Precision Oncology Program: Balancing Access with Rapid Learning in Molecular Cancer MedicineBiomarkers in Cancer201619
45PET Metabolic Biomarkers for CancerBiomarkers in Cancer201617
46A Standardized and Reproducible Urine Preparation Protocol for Cancer Biomarkers DiscoveryBiomarkers in Cancer201416
47In Search for Optimal Targets for Intraoperative Fluorescence Imaging of Peritoneal Metastasis From Colorectal CancerBiomarkers in Cancer201716
48Gastrointestinal Stromal Tumors (GIST): A Prospective Analysis and an Update on Biomarkers and Current Treatment ConceptsBiomarkers in Cancer201516
49Potential Biomarkers in the Sera of Breast Cancer Patients from Bahawalpur, PakistanBiomarkers in Cancer201214
50Can Immunohistochemistry Serve as an Alternative to Subjective Histopathological Diagnosis of Oral Epithelial Dysplasia?Biomarkers in Cancer201313